Qatar-based healthtech startup Lillia has achieved two significant international milestones, cementing its position as a global innovator in the digital health space. The company was named one of the World’s Top Healthtech Companies of 2025 by TIME Magazine and also won the prestigious Builders | VC MENA HLTH Sponsorship Award. These accolades for co-founders Sujit Chakrabarty and Dr. Hessa Al-Jaber highlight the growing influence of the MENA region’s tech ecosystem on the world stage.
Global Recognition By TIME Magazine
Lillia was officially recognized by TIME in the World’s Top Healthtech Companies for 2025 list. The company was featured in the AI & Data Analytics category, where it earned a “Very High” performance indicator based on its strength in growth, reputation, and digital engagement. This distinction is particularly noteworthy as inclusion in TIME’s global ranking is based solely on independent, fact-driven research and cannot be purchased or influenced. For the Lillia team, the recognition reaffirms their mission to build digital health solutions of global relevance.
Showcasing Qatari Innovation In Las Vegas
In addition to the TIME feature, Lillia was announced as the winner of the Builders | VC MENA HLTH Sponsorship Award. This award includes a full sponsorship package valued at over $15,000, enabling the startup to exhibit at HLTH 2025 in Las Vegas this October. HLTH is considered one of the world’s premier digital health platforms, and this opportunity will allow Lillia to showcase its Qatari-born innovation on a global stage.
About Lillia
Founded in 2020, Lillia is a clinically proven, AI-powered platform designed to help healthcare providers, insurers, and corporations manage chronic diseases effectively. Since its inception, Lillia has transformed 40,000 lives across the GCC region and India, working with 20 institutional customers. The platform has demonstrated significant results, with 85% of high-risk users seeing a reduction in blood sugar, 80% of users losing 5% of their body weight, and 35% of users reducing medication dependence within three months. Lillia is currently preparing for expansion across the MENA and South East Asia regions.
